Neuspera Medical Raises $23 Million in Series D Financing
Cala receives positive coverage decision from CMS
Exo Launches FDA Cleared AI for HF
CVRx announces additional data supporting long term benefits of Barostim
Saluda receives coverage from major payers
Onc.AI to present results from collaboration with Pfizer, showing immunotherapy response prediction using a radiomic signature
Setpoint receives FDA breakthrough device designation for Multiple Sclerosis
Exo implements ExoWorks in Wellstar and shows 47% increase in revenue capture
CVRx announces new CEO
This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249. Monday-Friday, 8:00 am - 6:00 pm ET
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.